Last Price
0.032
Today's Change
0.00 (0.00%)
Day's Change
0.031 - 0.033
Trading Volume
1,066,955
Market Cap
24 Million
Shares Outstanding
769 Million
Avg Volume
2,787,958
Avg Price (50 Days)
0.04
Avg Price (200 Days)
0.05
PE Ratio
-1.07
EPS
-0.03
Earnings Announcement
01-Nov-2024
Previous Close
0.03
Open
0.03
Day's Range
0.031 - 0.033
Year Range
0.028 - 0.1075
Trading Volume
1,066,955
1 Day Change
0.00%
5 Day Change
-5.88%
1 Month Change
-25.58%
3 Month Change
-16.82%
6 Month Change
-31.79%
Ytd Change
-57.33%
1 Year Change
-51.97%
3 Year Change
-95.37%
5 Year Change
-97.17%
10 Year Change
-97.17%
Max Change
-97.17%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.